Waters' Q3 Sales, Profit Jump as US Pharma Spending Recovers; Targets LC, MS Growth | GenomeWeb
Waters this week posted 10-percent revenue growth and said its profit nearly doubled for the third quarter as spending by large pharmaceutical customers improved, reversing a negative trend from the past several quarters.
 

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

An opinion piece in the New York Times urges lawmakers to keep genetic protections in place.

Research funding in Canada is to remain mostly the same, ScienceInsider reports.

In Science this week: random DNA replication errors play role in cancer, and more.

The Bill and Melinda Gates Foundation embarks on an open-access publishing path.